Biocytogen Pharmaceuticals Co. Ltd. (I54)
Market Open
11 Aug, 13:26
€
7. 35
-0.05
-0.6757%
€
2.22B Market Cap
- P/E Ratio
- Div Yield
100 Volume
- Eps
€ 7.4
Previous Close Want to track I54 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biocytogen Pharmaceuticals Co. Ltd. (I54) Statistics
Valuation metrics
Market Cap 2.22B
Enterprise value 260.98M
Trailing P/E (ttm) 109
Forward P/E -
PEG ratio -
Price/Sales (ttm) 1.55
Price/Book (mrq) 8.54
Enterprise Value/Revenue 1.32
Enterprise Value/EBITDA 4.73
Overview
Shares outstanding 107.36M
Float 158.02M
Shares short -
% Held by insiders 0.34%
% Held by institutions 0.34%
Average volume (10 days) 60
Average volume (90 days) 97
Price summary
52-Week low 2.33
52-Week high 7.4
Beta 0.13
50-Day moving average 6
200-Day moving average 4.22
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.19%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.19%
Income Statement
Revenue (ttm) 197.13M
Revenue per share (ttm) 3.85
Quarterly revenue growth (yoy) 0.74%
Gross profit (ttm) 150.16M
EBITDA 416.49M
Net income to common (ttm) 36.65M
Diluted EPS (ttm) 0.05
Quarterly earnings growth (yoy) -0.56%
Balance Sheet
Total cash (mrq) 155.32M
Total cash per share (mrq) 2.75
Total debt (mrq) 125.37M
Total Debt/Equity (mrq) 43.46
Current ratio (mrq) 2.7%
Book value per share (mrq) 0.64
Cash Flow
Cash flow statement 60.7M
Levered free cash flow (LFCF) 807.26K
